BIR Theranostics Series: Prostate Cancer

British Institute of Radiology (BIR) Theranostics Series: Prostate Cancer is organized by British Institute of Radiology (BIR) and will be held on Feb 05, 2018 at The Royal Society of Medicine, London, England, United Kingdom.

The target audience for this medical event is nuclear medicine physicians, radiologists, oncologists, onco-surgeons, trainees, clinical physicists, technologists and health-care managers. This CME Conference has been approved for a maximum of 7 CPD Credits.

Conference Description :
The Purpose of this conference is to discover an integrated approach of imaging in the diagnosis and treatment of prostate cancer.

In This conference our renowned international multidisciplinary faculty of expert oncologists, surgeons, radiologists and nuclear medicine physicians will provide a comprehensive overview of imaging technology and therapies. Attendees will develop their skills in the management of prostate cancer with talks covering radiological imaging, PET/CT, radionuclide therapy, early stage diagnosis and hormone sensitive advanced prognosis. There will also be opportunities for case-based discussions with our expert panel.

Session 1 : Management of prostate cancer
Session 2 : Radionuclide imaging

Additional details will be posted as soon as they are available.